Ask the Experts: Respiratory syncytial virus (RSV): Contraindications & Precautions (Vaccines and Antibody)

Results (2)

Nirsevimab is contraindicated in persons with a history of severe allergic reactions (e.g., anaphylaxis) after a previous dose or to a product component. As with any injection, when administering nirsevimab to children with increased risk for bleeding, providers should follow ACIP’s general best practice guidelines for immunization.

Last reviewed: January 22, 2024

RSV vaccines are contraindicated for and should not be administered to persons with a history of severe allergic reaction, such as anaphylaxis, to any component of the vaccine. People experiencing moderate or severe acute illness with or without fever should delay RSV vaccination until they are improved, as a precaution.

Last reviewed: January 22, 2024

This page was updated on .